Gene silencing in the endocrine pancreas mediated by short-interfering RNA

Sean P Bradley1, Cristiana Rastellini, Marco A da Costa

  • 1Department of Surgery, Division of Transplantation, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Pancreas
|November 1, 2005
PubMed
Abstract

Insights

Short-interfering RNA (siRNA) successfully silenced the Ins2 gene in pancreatic islets, demonstrating a novel gene therapy approach for endocrine pancreas research. This study highlights siRNA

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Endocrinology

Background:

  • RNA interference (RNAi) using short-interfering RNA (siRNA) is a nonviral gene silencing method.
  • Limited data exist on siRNA applications in pancreatic tissue for gene therapy.
  • Developing effective gene silencing in pancreatic islets is crucial for research and therapeutic strategies.

Purpose of the Study:

  • To investigate the efficacy of siRNA in silencing an endogenous gene within pancreatic islets.
  • To establish a murine model for studying siRNA-mediated gene therapy in the endocrine pancreas.

Main Methods:

  • Targeted the insulin 2 (Ins2) gene using siRNA in isolated pancreatic islets.
  • Utilized quantitative RT-PCR, fluorescent microscopy, and FACS to assess gene silencing and siRNA delivery.
  • Administered siRNA via in vitro liposomal transfection and in vivo hydrodynamic tail vein injection in mice.

Main Results:

  • In vitro, a 55% reduction in Ins2 transcript levels was achieved with 400 nM siRNA, showing over 45% transfection efficiency.
  • In vivo, pancreatic islets showed a 33% decrease in Ins2 mRNA levels after siRNA administration.
  • siRNA was detected in 19% of isolated islet cells following in vivo delivery.

Conclusions:

  • Successfully demonstrated RNA interference for silencing the endogenous, tissue-specific Ins2 gene in pancreatic islets.
  • Validated both in vitro and in vivo siRNA delivery methods for gene silencing in pancreatic islets.
  • Provides a foundation for exploring siRNA-based gene therapy in pancreatic diseases.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...